{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:26:34Z","timestamp":1773051994367,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Eccrine porocarcinoma is a rare cutaneous adnexal malignancy. Factors associated with metastasis of porocarcinoma and evidence for the utility of sentinel lymph node biopsy are incomplete within the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Determine prognostic factors that may guide the decision to pursue sentinel lymph node biopsy in patients with porocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Retrospective analysis of the National Cancer Database and the Survival, Epidemiology, and End Results databases for cases of porocarcinoma. Multivariable logistic regression was performed examining tumor size and lymphovascular invasion for association with metastasis of porocarcinoma. The cumulative probability of sentinel node metastasis was calculated as a function of tumor size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 1,351 patients were identified; 75 (5.6%) had a positive lymph node on pathology and 15 (1.1%) had distant metastatic disease. Patients with tumors greater than 17 mm in size had a 6.8% risk of occult lymph node metastasis identified by sentinel lymph node biopsy. In the subset of tumors analyzed for lymphovascular invasion, 40% (14 of 47) had metastasized at diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Tumor size and lymphovascular invasion affect metastasis of porocarcinoma. Tumors greater than 17 mm in size or with lymphovascular invasion warrant consideration of sentinel lymph node biopsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004737","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:01:14Z","timestamp":1751961674000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Factors Associated With Metastasis of Eccrine Porocarcinoma: A Retrospective Cohort Analysis of National Cancer Databases"],"prefix":"10.1097","volume":"52","author":[{"given":"Christopher R.","family":"Cullison","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland;"},{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaden M.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke D.","family":"Rothermel","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Hoehn","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghav","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland;"},{"name":"Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland;"},{"name":"Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/DSS.0000000000003652","article-title":"Epidemiology and survival of eccrine porocarcinoma by sex in the United States: a surveillance, epidemiology, and end results database analysis","volume":"49","author":"Ragi","year":"2023","journal-title":"Dermatol Surg"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/jcm11082185","article-title":"Head and neck porocarcinoma: SEER analysis of epidemiology and survival","volume":"11","author":"Scampa","year":"2022","journal-title":"J Clin Med"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaad.2022.04.052","article-title":"Incidence and trends of cutaneous adnexal tumors in the United States in 2000-2018: a population-based study","volume":"88","author":"Gibbs","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00000478-200106000-00002","article-title":"Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases","volume":"25","author":"Robson","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R5-20251218","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.3390\/cancers14215232","article-title":"Diagnosis and management of porocarcinoma","volume":"14","author":"Miyamoto","year":"2022","journal-title":"Cancers"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amsu.2017.06.027","article-title":"Porocarcinoma; presentation and management, a meta-analysis of 453 cases","volume":"20","author":"Salih","year":"2017","journal-title":"Ann Med Surg"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.annder.2013.10.047","article-title":"Primary eccrine porocarcinoma: a clinicopathological study of 50 cases [in French]","volume":"141","author":"Skowron","year":"2014","journal-title":"Ann Dermatol Venereol"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/ijd.16129","article-title":"Porocarcinoma: an epidemiological, clinical, and dermoscopic 20-year study","volume":"61","author":"De Giorgi","year":"2022","journal-title":"Int J Dermatol"},{"key":"R9-20251218","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/hed.26178","article-title":"Eccrine porocarcinoma of the head and neck: meta-Analysis of 120 cases","volume":"42","author":"Le","year":"2020","journal-title":"Head Neck"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2133.2011.10486.x","article-title":"Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure","volume":"165","author":"Belin","year":"2011","journal-title":"Br J Dermatol"},{"key":"R11-20251218","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/DSS.0000000000000382","article-title":"Eccrine porocarcinoma treated by mohs micrographic surgery: over 6-Year Follow-up of 12 cases and literature review","volume":"41","author":"Xu","year":"2015","journal-title":"Dermatol Surg"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.25251\/skin.7.6.13","article-title":"Comparing porocarcinoma outcomes following resection by surgical management technique","volume":"7","author":"Shope","year":"2023","journal-title":"SKIN J Cutenaous Med"},{"key":"R13-20251218","first-page":"301","article-title":"Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature","volume":"41","author":"Song","year":"2015","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jamcollsurg.2021.01.019","article-title":"Malignant cutaneous adnexal tumors and role of SLNB","volume":"232","author":"Storino","year":"2021","journal-title":"J Am Coll Surg"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2340\/00015555-3173","article-title":"Evaluation of sentinel lymph node biopsy for eccrine porocarcinoma","volume":"99","author":"Tsunoda","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2022.12.014","article-title":"Predictors of receipt of sentinel lymph node biopsy in patients with malignant adnexal tumors of the skin","volume":"88","author":"Joel","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R18-20251218","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijscr.2018.10.047","article-title":"Sentinel lymph node biopsy in porocarcinoma: a case reports","volume":"53","author":"Reina","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"adv11649","DOI":"10.2340\/actadv.v103.11649","article-title":"Eccrine porocarcinoma: clinical and histopathological study of 14 patients with special emphasis on sentinel lymph node biopsy","volume":"103","author":"Meril\u00e4inen","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MLR.0b013e318297429c","article-title":"Why summary comorbidity measures such as the charlson comorbidity index and elixhauser score work","volume":"53","author":"Austin","year":"2015","journal-title":"Med Care"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/ije\/29.5.891","article-title":"Use of comorbidity scores for control of confounding in studies using administrative databases","volume":"29","author":"Schneeweiss","year":"2000","journal-title":"Int J Epidemiol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:00:39Z","timestamp":1766084439000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004737","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}